Investment
Features
FeesSafety
Academy
More
Pluang+

Deep Fission IPO stock dips amid technical selling, but strong project pipeline offers upside.

Market News
14 Jul 2026
Seeking Alpha
View Source
Bullish
Deep Fission IPO stock dips amid technical selling, but strong project pipeline offers upside.

Deep Fission recently completed its NASDAQ IPO, but its stock has underperformed due to technical selling, low market awareness, and skepticism about its development stage. The company focuses on commercializing a borehole nuclear reactor using conventional technology and established methods, differentiating itself by advancing a reactor configuration intended for commercialization rather than just experimental setups. With an 18.5 GW letter of intent pipeline and a valuation discount compared to peers, Deep Fission has significant growth potential if it meets key technical, regulatory, and financing milestones. The next major catalyst is a planned 2,000–2,500 foot proof-of-concept borehole to test deployment assumptions in the field.

More News

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Two directors of Equitable Holdings sold shares recently, with Bertram L. Scott selling 2,780 shares and Craig C. MacKay selling 2,000 shares. Meanwhile, institutional investors showed mixed activity: Engineers Gate Manager LP drastically cut its hol...

Market News
Neutral
1 hour ago
Greenland mining and chip ETFs soar on new security deal and AI optimism

Greenland mining and chip ETFs soar on new security deal and AI optimism

Shares of Greenland-linked mining companies surged following a new U.S.-Denmark-Greenland security agreement that boosted investor interest in Greenland's mineral resources. Greenland Mines Ltd. jumped over 229%, while Critical Metals Corp. rose near...

Market News
Bullish
1 hour ago
Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs were the biggest losers in the market, with Cue Biopharma dropping 23.7% despite positive Phase 2 clinical results. Leveraged ETFs tied to AMD, Strategy, and Novo Nordisk also saw sharp declines due to their daily-re...

Market News
Bearish
1 hour ago
Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology Holdings is being taken private in a $1.6 billion deal led by its Chairman and CEO, Thomas Priore. The acquisition price is $8.05 per share, matching the analyst price target set by Lake Street, which downgraded the stock to 'Hold...

Company Fundamentals
Neutral
2 hours ago
General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills is set to report its Q3 2026 earnings with an expected 16.3% decline in earnings per share to $0.72 and revenue forecast around $4.35 billion, down from last year. Despite these declines, the company reaffirmed its full-year adjusted EP...

Company Fundamentals
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App